Research – Clinical Trial of Ambroxol in Parkinson’s Dementia

This study will investigate whether a drug called Ambroxol can improve the course of Parkinson’s Dementia.

Participants should be:

  • Over 50
  • Have a diagnosis of Parkinson’s with cognitive impairment (e.g., forgetfulness)
  • Have a Caregiver
  • Be able to perform memory, movement (e.g., walking) and laboratory tests (e.g., blood draw)

 

For more information, please contact Carolina Silveira, Clinical Trial Coordinator 519-646-6100 ext. 42367